Tibet Urban Development and Investment Co.,LTD (SHA:600773)

Blueprint Medicines Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	1,596	1,138	2,355	2,430	2,495	1,847
Other Revenue	45.27	45.27	40.11	26.78	19.13	16.95
Revenue	1,641	1,183	2,395	2,456	2,514	1,864
Revenue Growth (YoY)	-10.85%	-50.61%	-2.49%	-2.31%	34.91%	38.70%
Cost of Revenue	1,482	1,022	1,610	1,714	1,801	1,258
Gross Profit	159.91	160.56	784.97	742.23	713.84	606.13
Selling, General & Admin	252.14	251.81	232.94	251.23	231.97	207.88
Other Operating Expenses	56	54.67	304.41	184.14	133.47	139.72
Operating Expenses	302.65	301.16	540.32	436.73	366.5	348.07
Operating Income	-142.74	-140.6	244.65	305.49	347.35	258.05
Interest Expense	-119.96	-123.54	-146.4	-180.51	-113.33	-50.57
Interest & Investment Income	351.73	350.34	5.44	35.35	12.84	13.52
Other Non Operating Income (Expenses)	-3.21	-3.12	-2.84	-7.7	-1.75	-1.18
EBT Excluding Unusual Items	85.82	83.07	100.84	152.63	245.11	219.83
Gain (Loss) on Sale of Investments	9.18	-	-42.96	-	-15.85	-9.12
Gain (Loss) on Sale of Assets	0.16	0.16	0.03	0.13	-0.01	-0.01
Asset Writedown	-36.12	-36.12	-	-	-	-
Other Unusual Items	-0.22	-0.03	-0.06	0.28	-4.45	-8.63
Pretax Income	58.82	47.08	57.85	153.05	224.81	202.07
Income Tax Expense	87.19	84.96	61.98	105.28	113.39	95.59
Earnings From Continuing Operations	-28.37	-37.88	-4.12	47.77	111.41	106.48
Minority Interest in Earnings	55.91	50.43	66.12	69.48	7.05	4.75
Net Income	27.55	12.55	61.99	117.25	118.46	111.23
Net Income to Common	27.55	12.55	61.99	117.25	118.46	111.23
Net Income Growth	-	-79.76%	-47.13%	-1.02%	6.50%	4.56%
Shares Outstanding (Basic)	1,288	1,255	775	837	846	794
Shares Outstanding (Diluted)	1,288	1,255	775	837	846	794
Shares Change (YoY)	66.10%	61.95%	-7.47%	-1.02%	6.50%	-2.91%
EPS (Basic)	0.02	0.01	0.08	0.14	0.14	0.14
EPS (Diluted)	0.02	0.01	0.08	0.14	0.14	0.14
EPS Growth	-	-87.50%	-42.86%	-	-	7.69%
Free Cash Flow	-489.76	-527.95	-586.36	929.37	-297.41	528.85
Free Cash Flow Per Share	-0.38	-0.42	-0.76	1.11	-0.35	0.67
Dividend Per Share	0.010	0.010	0.010	0.016	0.018	0.010
Dividend Growth	-	-	-37.50%	-11.11%	80.00%	-33.33%
Gross Margin	9.74%	13.57%	32.77%	30.21%	28.39%	32.52%
Operating Margin	-8.70%	-11.88%	10.21%	12.44%	13.81%	13.84%
Profit Margin	1.68%	1.06%	2.59%	4.77%	4.71%	5.97%
Free Cash Flow Margin	-29.84%	-44.63%	-24.48%	37.83%	-11.83%	28.37%
EBITDA	-51.86	-50.12	333.51	381.37	397.16	309.59
EBITDA Margin	-3.16%	-4.24%	13.92%	15.53%	15.79%	16.61%
D&A For EBITDA	90.88	90.48	88.86	75.88	49.81	51.53
EBIT	-142.74	-140.6	244.65	305.49	347.35	258.05
EBIT Margin	-8.70%	-11.88%	10.21%	12.44%	13.81%	13.84%
Effective Tax Rate	148.22%	180.47%	107.13%	68.79%	50.44%	47.30%
Revenue as Reported	1,641	1,183	2,395	2,456	2,514	1,864
Advertising Expenses	-	28.35	21.81	26.65	24.12	15.74

Source: S&P Global Market Intelligence. Standard template. Financial Sources.